Vita 34 AG · ISIN: DE000A0BL849 · EQS - adhoc news

Vita 34 closes 2023 with significantly better results than expected based on preliminary figures

Vita 34 closes 2023 with significantly better results than expected based on preliminary figures Leipzig, 19 April 2024 – According to the final key financial figures for fiscal year 2023 available today, Vita 34 AG closed the year significantly better in terms of earnings than expected by the Management Board on the basis of the preliminary business figures from the end of January. Accordingly, earnings before interest, taxes, depreciation and amortization (EBITDA) amounted to EUR 5.6 million....

XETR:V3V Price indication powered by TradingView

About the publication

Corporate Insights - Short Sales, Director's Dealings, Sentiment Indicators - THE info hub for the informed investor

Smart tools for smart investors can be found in our Tools section

Corporate News Vita 34 AG

In this overview you can view company news in the chronological order of publication. The source information comes from EQS News, the leading European news distributor. The most recent news item is listed first.
Back to Corporate News Overview
This might be interesting for you as well
Analyst Ratings (0)
Directors Dealings (4)
Short Selling (DE) (0)
Short Selling (UK) (0)
19 April 2024 12:28PM
Vita 34 closes 2023 with significantly better results than expected based on preliminary figures
DE000A0BL849
Vita 34 closes 2023 with significantly better results than expected based on preliminary figures Leipzig, 19 April 2024 – According to the final key financial figures for fiscal year 2023 available today, Vita 34 AG closed the year significantly better in terms of earnings than expected by the Management Board on the basis of the preliminary busin...
Vita 34 AG
About the publication
31 January 2024 05:03PM
Vita 34 publishes preliminary figures on the course of business in 2023
DE000A0BL849
Vita 34 publishes preliminary figures on the course of business in 2023 Leipzig, 31 January 2024 - Vita 34 AG closed the year 2023, in view of a challenging environment, solidly from a purely operational perspective. However, a number of extraordinary charges caused the earnings development to fall short of expectations. Based on initial prelimin...
Vita 34 AG
About the publication
02 January 2024 12:13PM
Vita 34 downsizes Management Board until further notice
DE000A0BL849
Vita 34 downsizes Management Board until further notice CFO Dirk Plaga stepped down from the Management Board as of 31 December 2023 Management Board to be temporarily reduced from three to two members Leipzig, 2 January 2024 – Vita 34 AG, the leading cell bank in Europe and the third largest in the world, is making changes to its Management Boar...
Vita 34 AG
About the publication
27 November 2023 11:37AM
resolves on cash capital increase under exclusion of subscription rights in the amount of up to 10% of the share capital, commitments from investors
DE000A0BL849
  THE INFORMATION CONTAINED IN THIS ANNOUNCEMENT IS NOT FOR PUBLICATION OR DISTRIBUTION IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA OR JAPAN OR ANY OTHER JURISDICTION WHERE SUCH DISTRIBUTION OR PUBLICATION WOULD BE UNLAWFUL.   Vita 34 AG resolves on cash capital increase under exclusion of subscription rights in the amount of up t...
Vita 34 AG
About the publication
24 November 2023 07:00AM
Vita 34 increases revenue and earnings in Q3 2023 and further stabilizes business development
DE000A0BL849
Vita 34 increases revenue and earnings in Q3 2023 and further stabilizes business development Revenues increased solidly by 11.7 percent to EUR 56.7 million in the first nine months of 2023 Adjusted pricing models and internal efficiency programs provide positive impetus EBITDA further improved versus last year and versus Q2 to EUR 3.6 million ...
Vita 34 AG
About the publication
10 November 2023 02:57PM
Internal investigation by Vita 34 AG reveals irregularities related to a limited number of biological samples at one of its subsidiaries regarding compliance with medical law requirements
DE000A0BL849
Internal investigation by Vita 34 AG reveals irregularities related to a limited number of biological samples at one of its subsidiaries regarding compliance with medical law requirements Leipzig, 10 November 2023 - Based on an internal notice, Vita 34 AG has conducted an investigation at one of its small subsidiaries. This revealed potential irre...
Vita 34 AG
About the publication
27 September 2023 07:21PM
A subsidiary of Vita 34, FamiCordTx, will file a lawsuit against a US licensor
DE000A0BL849
  Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014   A subsidiary of Vita 34, FamiCordTx, will file a lawsuit against a US licensor Leipzig, [27 Sept 2023] – Polski Bank Komórek Macierzystych (“PBKM”), a fully owned subsidiary of Vita 34 AG announced on January 2, 2020, that PBKM´s subsidiary FamiCor...
Vita 34 AG
About the publication
31 August 2023 10:30AM
Vita 34 stabilizes business development in the second quarter and noticeably improves earnings
DE000A0BL849
Vita 34 stabilizes business development in the second quarter and noticeably improves earnings Revenues in the first half of 2023 up 13.0 percent to EUR 36.3 million EBITDA significantly increased to EUR 1.6 million compared with both the previous year and the first quarter of 2023 Operating cash flow significantly improved to EUR 2.9 million G...
Vita 34 AG
About the publication
31 May 2023 08:00AM
Vita 34 successfully implements price increases in first quarter of 2023 in generally weak market environment
DE000A0BL849
Vita 34 successfully implements price increases in first quarter of 2023 in generally weak market environment First quarter sales up 15.7 percent to EUR 17.9 million Gross profit benefits from price adjustments and cost discipline and increases by 58.2 percent to EUR 5.7 million EBITDA in positive territory at EUR 0.3 million after significantly...
Vita 34 AG
About the publication
31 May 2023 08:00AM
Vita 34 successfully implements price increases in first quarter of 2023 in generally weak market environment
DE000A0BL849
Vita 34 successfully implements price increases in first quarter of 2023 in generally weak market environment First quarter sales up 15.7 percent to EUR 17.9 million Gross profit benefits from price adjustments and cost discipline and increases by 58.2 percent to EUR 5.7 million EBITDA in positive territory at EUR 0.3 million after significantly...
Vita 34 AG
About the publication
12 May 2023 09:10AM
Vita 34 Starts Recruitment for Clinical Trial with CAR-T Drug Candidate
DE000A0BL849
Vita 34 Starts Recruitment for Clinical Trial with CAR-T Drug Candidate Approval by responsible authorities and ethics committee granted Recruitment of the first patient imminent Completion of Phase I expected by the end of 2023 Leipzig, 12 May 2023 - Vita 34 AG (ISIN: DE000A0BL849; WKN: A0BL84), the leading cell bank in Europe and the third lar...
Vita 34 AG
About the publication
12 May 2023 09:10AM
Vita 34 Starts Recruitment for Clinical Trial with CAR-T Drug Candidate
DE000A0BL849
Vita 34 Starts Recruitment for Clinical Trial with CAR-T Drug Candidate Approval by responsible authorities and ethics committee granted Recruitment of the first patient imminent Completion of Phase I expected by the end of 2023 Leipzig, 12 May 2023 - Vita 34 AG (ISIN: DE000A0BL849; WKN: A0BL84), the leading cell bank in Europe and the third lar...
Vita 34 AG
About the publication
30 April 2023 12:00PM
Development of Vita 34 AG in 2022 stressed by weakened consumption power of consumers along with one-off effects
DE000A0BL849
Development of Vita 34 AG in 2022 stressed by weakened consumption power of consumers along with one-off effects Group revenue of EUR 68.9 million 142.6 percent above previous year after merger with PBKM FamiCord (Guidance: EUR 65 to 72 million) EBITDA of EUR -3.6 million, mostly due to one-off effects under IFRS-15 (Guidance: EUR -6.0 to -3.0 mi...
Vita 34 AG
About the publication
30 April 2023 12:00PM
Development of Vita 34 AG in 2022 stressed by weakened consumption power of consumers along with one-off effects
DE000A0BL849
Development of Vita 34 AG in 2022 stressed by weakened consumption power of consumers along with one-off effects Group revenue of EUR 68.9 million 142.6 percent above previous year after merger with PBKM FamiCord (Guidance: EUR 65 to 72 million) EBITDA of EUR -3.6 million, mostly due to one-off effects under IFRS-15 (Guidance: EUR -6.0 to -3.0 mi...
Vita 34 AG
About the publication
25 April 2023 06:43PM
Vita 34 AG publishes outlook for the 2023 financial year
DE000A0BL849
Vita 34 AG publishes outlook for the 2023 financial year Leipzig, April 25, 2023 - In the context of the preparation of the consolidated financial statements 2022, the Management Board today approved the outlook report on the expected business development of Vita 34 AG in the 2023 financial year. Based on current analyst estimates, the Management ...
Vita 34 AG
About the publication
25 April 2023 06:43PM
Vita 34 AG publishes outlook for the 2023 financial year
DE000A0BL849
Vita 34 AG publishes outlook for the 2023 financial year Leipzig, April 25, 2023 - In the context of the preparation of the consolidated financial statements 2022, the Management Board today approved the outlook report on the expected business development of Vita 34 AG in the 2023 financial year. Based on current analyst estimates, the Management ...
Vita 34 AG
About the publication
06 April 2023 08:39PM
2022 annual result of Vita 34 AG significantly influenced by impairment of goodwill
DE000A0BL849
2022 annual result of Vita 34 AG significantly influenced by impairment of goodwill Leipzig, 6 April 2023 - As part of the 2022 audit of the consolidated financial statements, the Group's auditor PwC today materially completed the impairment test of goodwill. This results in a non-cash impairment totaling EUR 13.8 million, which is largely based o...
Vita 34 AG
About the publication
06 April 2023 08:39PM
2022 annual result of Vita 34 AG significantly influenced by impairment of goodwill
DE000A0BL849
2022 annual result of Vita 34 AG significantly influenced by impairment of goodwill Leipzig, 6 April 2023 - As part of the 2022 audit of the consolidated financial statements, the Group's auditor PwC today materially completed the impairment test of goodwill. This results in a non-cash impairment totaling EUR 13.8 million, which is largely based o...
Vita 34 AG
About the publication
22 November 2022 03:51PM
Vita 34 benefits from increasing normalization in its core business in the third quarter
DE000A0BL849
Vita 34 benefits from increasing normalization in its core business in the third quarter Revenues for the first nine months rose to EUR 50.8 million; business development gains further momentum in the third quarter EBITDA of EUR -1.6 million in the first nine months below previous year due to continued investments in the new activities, but alrea...
Vita 34 AG
About the publication
22 November 2022 03:51PM
Vita 34 benefits from increasing normalization in its core business in the third quarter
DE000A0BL849
Vita 34 benefits from increasing normalization in its core business in the third quarter Revenues for the first nine months rose to EUR 50.8 million; business development gains further momentum in the third quarter EBITDA of EUR -1.6 million in the first nine months below previous year due to continued investments in the new activities, but alrea...
Vita 34 AG
About the publication
30 August 2022 07:20PM
Vita 34 records moderate upward trend in the second quarter
DE000A0BL849
Vita 34 records moderate upward trend in the second quarter - Revenues in the first half of the year show significant increase to EUR 32.1 million due to fully consolidated results coming from business combination with PBKM FamiCord - As expected, EBITDA of EUR -2.6 million still significantly impacted by further investments in R&D, newly de...
Vita 34 AG
About the publication
30 August 2022 07:20PM
Vita 34 records moderate upward trend in the second quarter
DE000A0BL849
Vita 34 records moderate upward trend in the second quarter - Revenues in the first half of the year show significant increase to EUR 32.1 million due to fully consolidated results coming from business combination with PBKM FamiCord - As expected, EBITDA of EUR -2.6 million still significantly impacted by further investments in R&D, newly de...
Vita 34 AG
About the publication
29 August 2022 11:25PM
Vita 34 lowers sales and earnings guidance due to IFRS 15 effect and accelerated restructuring measures
DE000A0BL849
Vita 34 lowers sales and earnings guidance due to IFRS 15 effect and accelerated restructuring measures Leipzig, 29 August 2022 - In close coordination with its legal and business advisors, Vita 34 AG has today succeeded in reaching an agreement to structure its storage contracts with customers in the PBKM subgroup in such a way that they can be ...
Vita 34 AG
About the publication
29 August 2022 11:25PM
Vita 34 lowers sales and earnings guidance due to IFRS 15 effect and accelerated restructuring measures
DE000A0BL849
Vita 34 lowers sales and earnings guidance due to IFRS 15 effect and accelerated restructuring measures Leipzig, 29 August 2022 - In close coordination with its legal and business advisors, Vita 34 AG has today succeeded in reaching an agreement to structure its storage contracts with customers in the PBKM subgroup in such a way that they can be ...
Vita 34 AG
About the publication
29 June 2022 01:22PM
Vita 34 introduces new Chief Financial Officer at the Annual General Meeting
DE000A0BL849
Vita 34 introduces new Chief Financial Officer at the Annual General Meeting Dirk Plaga presented as new Chief Financial Officer of the Group with effect from 1 August Interim CFO Andreas Schafhirt continues to support post-merger integration as advisor High level of approval for all items on the agenda Leipzig, 29 June, 2022 - Vita 34 AG (ISIN:...
Vita 34 AG
About the publication
29 June 2022 01:22PM
Vita 34 introduces new Chief Financial Officer at the Annual General Meeting
DE000A0BL849
Vita 34 introduces new Chief Financial Officer at the Annual General Meeting Dirk Plaga presented as new Chief Financial Officer of the Group with effect from 1 August Interim CFO Andreas Schafhirt continues to support post-merger integration as advisor High level of approval for all items on the agenda Leipzig, 29 June, 2022 - Vita 34 AG (ISIN:...
Vita 34 AG
About the publication
30 April 2022 11:45PM
Vita 34 AG: Special items reflected in significant decline in earnings despite operational success in fiscal 2021
DE000A0BL849
Special items reflected in significant decline in earnings despite operational success in fiscal 2021 - Revenues of EUR 28.4 million after first-time consolidation of PBKM FamiCord up 44.5 percent on previous year as of 8 November - EBITDA after special effects down significantly at EUR 0.8 million- Core operating business weakened at the end of th...
Vita 34 AG
About the publication
29 April 2022 09:12PM
Vita 34 publishes revenue and earnings forecast for the 2022 financial year
DE000A0BL849
Vita 34 publishes revenue and earnings forecast for the 2022 financial year Leipzig, 29 April 2022 - On the basis of the current assessment of business performance and against the backdrop of the tense economic environment, the Management Board expects consolidated revenues of between EUR 68 million and EUR 75 million for the full year 2022 (2021:...
Vita 34 AG
About the publication
26 April 2022 08:26PM
2021 financial figures of Vita 34 AG expected to be significantly below market expectations due to several special effects on earnings development
DE000A0BL849
2021 financial figures of Vita 34 AG expected to be significantly below market expectations due to several special effects on earnings development Leipzig, 26 April 2022 - Based on the preliminary business figures on the corporate development of Vita 34 AG in 2021, which were audited by the auditor PWC, the company's Management Board assumes that ...
Vita 34 AG
About the publication
18 March 2022 08:21PM
Vita 34 sets course for accelerated growth in new business areas with changes in the Management Board
DE000A0BL849
Vita 34 sets course for accelerated growth in new business areas with changes in the Management Board - PBKM CEO Jakub Baran takes over from Dr. Wolfgang Knirsch as Chairman of the Management Board - Tomasz Baran, member of the Management Board of PBKM, is appointed to the newly created position of Chief Commercial Officer (CCO) on the Management ...
Vita 34 AG
About the publication
18 March 2022 08:20PM
Vita 34 AG: Change in the Chair of the Management Board
DE000A0BL849
Vita 34 AG: Change in the Chair of the Management Board Leipzig, 18 March 2022 - The Supervisory Board of Vita 34 AG has appointed Mr. Jakub Baran as a new member as well as the Chairman of the Management Board of the Company with effect from 22 March 2022. Jakub Baran is currently the Chairman of the Management Board of PBKM, a subsidiary of Vit...
Vita 34 AG
About the publication
15 December 2021 06:14PM
Vita 34 presents itself in new size for the first time at the Annual General Meeting 2021
DE000A0BL849
Vita 34 presents itself in new size for the first time at the Annual General Meeting 2021 - High level of approval from shareholders for accelerated growth course - New enlarged Supervisory Board presented and elected with large majority - Resolutions to enable capital raising support planned product launches and further completion of European mark...
Vita 34 AG
About the publication
11 November 2021 07:30AM
Vita 34 again increases sales and margins in the third quarter
DE000A0BL849
Vita 34 again increases sales and margins in the third quarter Revenues of EUR 16.6 million in the first nine months of 2021, up 11.7 percent on previous year Adjusted EBITDA up 16.1 percent to EUR 5.1 million Adjusted EBITDA margin at 30.4 percent, following on from previous records Leipzig, 11 November 2021 - Vita 34 AG (ISIN: DE000A0BL849; W...
Vita 34 AG
About the publication
09 November 2021 11:59AM
Vita 34 AG: Fulfilment of all closing conditions under the Exchange Offer PBKM; Implementation of capital increase; withdrawal of guidance for financial year 2021
DE000A0BL849
Vita 34 AG: Fulfilment of all closing conditions under the Exchange Offer PBKM; Implementation of capital increase; withdrawal of guidance for financial year 2021 Leipzig, 9 November 2021 - Vita 34 AG ("Vita 34") announces that all closing conditions under the voluntary public exchange offer by Vita 34 addressed to the shareholders of Polski Bank ...
Vita 34 AG
About the publication
28 October 2021 01:32PM
Vita 34 AG: Exchange Offer PBKM - 95% Minimum Acceptance Rate Exceeded
DE000A0BL849
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF APPLICABLE LAWS OR REGULATIONS Vita 34 AG: Exchange Offer PBKM - 95% Minimum Acceptance Rate Exceeded Leipzig, 28 October 2021 - Vita 34...
Vita 34 AG
About the publication
11 October 2021 08:00AM
Vita 34 AG extends the acceptance period under PBKM exchange offer
DE000A0BL849
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF APPLICABLE LAWS OR REGULATIONS Vita 34 AG extends the acceptance period under PBKM exchange offer - Vita 34 extended the acceptance peri...
Vita 34 AG
About the publication
20 September 2021 08:00AM
Vita 34 AG launches voluntary public exchange offer for PBKM shares
DE000A0BL849
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF APPLICABLE LAWS OR REGULATIONSVita 34 AG launches voluntary public exchange offer for PBKM shares Vita 34 published prospectus for volunt...
Vita 34 AG
About the publication
31 August 2021 07:30AM
Vita 34 again achieves double-digit growth in revenues and earnings in the first half of the year
DE000A0BL849
Vita 34 again achieves double-digit growth in revenues and earnings in the first half of the year - Revenues increase by 13.7 percent to EUR 10.8 million - Adjusted EBITDA rises disproportionately by 20.3 percent to EUR 3.2 million - Operating cash flow and liquidity reflect positive business performanceLeipzig, 31 August 2021 - Vita 34 AG (ISIN: ...
Vita 34 AG
About the publication
16 August 2021 09:30AM
Vita 34 AG: Andreas Schafhirt appointed as new Chief Financial Officer of Vita 34 AG
DE000A0BL849
Andreas Schafhirt appointed as new Chief Financial Officer of Vita 34 AG - Interim assumption of position until end of April 2022 - Previous CFO Falk Neukirch resigned from the company Leipzig, 16 August 2021 - The Supervisory Board of Vita 34 AG (ISIN: DE000A0BL849; WKN: A0BL84), one of Europe's largest cell banks, has appointed Andreas Schafhi...
Vita 34 AG
About the publication
13 July 2021 12:39PM
Vita 34 AG: Shareholders of Vita 34 AG approve capital increase in connection with the proposed business combination with Polski Bank Komórek Macierzystych S.A. via share exchange
DE000A0BL849
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF APPLICABLE LAWS OR REGULATIONS Vita 34 AG: Shareholders of Vita 34 AG approve capital increase in connection with the proposed business combination...
Vita 34 AG
About the publication
31 May 2021 11:00AM
Vita 34 publishes figures for the first quarter of 2021
DE000A0BL849
Vita 34 publishes figures for the first quarter of 2021 - Revenues in Q1 2021 at EUR 5.4 million after EUR 4.6 million in Q1 2020 - Adjusted EBITDA at EUR 1.7 million after EUR 1.1 million in Q1 2020 - Investments in marketing and sales reflected in increased demand in DACH region Leipzig, 31 May 2021 - Vita 34 AG (ISIN: DE000A0BL849; WKN: A0BL84...
Vita 34 AG
About the publication
31 May 2021 10:07AM
Vita 34 AG signs Business Combination Agreement with Polski Bank Komórek Macierzystych S.A.
DE000A0BL849
Vita 34 AG signs Business Combination Agreement with Polski Bank Komórek Macierzystych S.A. - Vita 34 AG ("Vita 34"), one of the largest cell banks in Europe, plans to combine its business with Polski Bank Komórek Macierzystych S.A. ("PBKM"), which leads FamiCord Group, Europe's largest stem cell bank. On 31 May the companies signed a Business Com...
Vita 34 AG
About the publication
31 May 2021 10:00AM
Vita 34 AG: Vita 34 AG and Warsaw-listed Polski Bank Komórek Macierzystych S.A. sign business combination agreement for potential combination via a share exchange
DE000A0BL849
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF APPLICABLE LAWS OR REGULATIONS Vita 34 AG: Vita 34 AG and Warsaw-listed Polski Bank Komórek Macierzystych S.A. sign business combination agreement f...
Vita 34 AG
About the publication
30 March 2021 07:30AM
Vita 34 continues to grow in 2020 in core markets after good year-end business
DE000A0BL849
Vita 34 continues to grow in 2020 in core markets after good year-end business Revenues slightly up on previous year at EUR 20.1 million after good fourth quarter Core markets in DACH show disproportionately strong gains and develop increasingly positively EBITDA reduces to EUR 5.3 million due to costs of takeover bid Leipzig, 30 March 2021 - V...
Vita 34 AG
About the publication
12 November 2020 07:30AM
Vita 34 manages crisis environment well with a strong third quarter
DE000A0BL849
Vita 34 manages crisis environment well with a strong third quarter Revenues after nine months of EUR 15.0 million almost at previous year's level EBITDA margin of 29.1 percent despite increased marketing expenses, close to the target of 30 percent Increased demand for new PUR price model leads to steady increase in recurring sales Leipzig, 12 N...
Vita 34 AG
About the publication
27 August 2020 07:30AM
Business development of Vita 34 gains significant momentum again in the second quarter
DE000A0BL849
Business development of Vita 34 gains significant momentum again in the second quarter Revenues up again significantly compared with the previous quarter EBITDA margin increases to 29.3 percent in the second quarter Good cash flow development allows cash and cash equivalents to rise significantly to EUR 9.9 million Leipzig, 27 August 2020 - The ...
Vita 34 AG
About the publication
More Vita 34 AG related information
Type Total Last Made by Go to
Corporate Research 0 - - Corporate Research
Directors Dealings 4 11th December 2023 Baran, Jakub Julian DD
Short Seller (DE) 0 - - SSR (DE)
Short Seller (UK) 0 - - SSR (UK)
Disclaimer:

The combination of information with graphic elements makes an important contribution to visual orientation and navigation through complex factual topics. Essential content features can be perceived, grasped and contextually processed much faster. 
The figurative marks, logos and other graphic and textual elements used on this website are for illustrative purposes only. All rights to the aforementioned elements are held by their respective owners. They are used without the intention of copyright infringement or intellectual property infringement.

If you believe that copyrights or intellectual property have been infringed by the choice of illustration, please contact us immediately to clarify the issue.

v.07062023 EN